Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v24-FR Version v18-FR
Language French French
Date Updated 2019-12-12 2019-09-19
Drug Identification Number 02439662 02439662
Brand name ACT BUPROPION XL ACT BUPROPION XL
Common or Proper name BUPROPION XL BUPROPION XL
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients BUPROPION HYDROCHLORIDE BUPROPION HYDROCHLORIDE
Strength(s) 300MG 300MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 500 500
ATC code N06AX N06AX
ATC description ANTIDEPRESSANTS ANTIDEPRESSANTS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2018-12-01 2018-12-01
Estimated end date 2020-01-31 2019-10-31
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments Allocating inventory to support regular demand. Cannot support increased demand for this molecule, as well as now delays in releases from the mfg site. Allocating inventory to support regular demand. Cannot support increased demand for this molecule, as well as now delays in releases from the mfg site.
Health Canada comments